Keva Health presented exciting new data at the AAAAI conference, highlighting the impact of our Predictive Analysis Model for Exacerbations in Asthmatic Patients on remote patient monitoring.
A leading allergist in Massachusetts shared, “We are using Keva remote monitoring program for our clinic patients. It has allowed us to create a comprehensive disease management program that improves clinical outcomes and enhances the patient care experience.”
Our Program revealed:
- 37% reduction in ER visits through proactive intervention
- Increased treatment adherence with real-time alerts and patient engagement
- Personalized risk stratification for high-risk and low-risk asthma patients
- Seamless integration with EMR systems, reducing provider workload
- Improved patient satisfaction with enhanced education and self-management tools
Jyotsna Mehta, CEO of Keva Health, shared: “We received a great response at AAAAI2025 – our real world evidence is promising and look forward to expanding remote respiratory care to more patients. We would appreciate connections to allergists and pulmonologists for introducing our program ”
For more, visit Keva Health’s website.
